Note: Ingredients listed on restricted chemical lists
EC/CAS
204-658-1/123-86-4
Name of the chemical
acetic acid, butyl ester
Concentration
>=1-<10
EC/CAS
247-714-0/9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
>=1-<10 >=1-<5 >=5% >=5% >=5% >=0,1%
EC/CAS
202-966-0/101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
>=1-<5 >=5% >=5% >=5% >=0,1%
EC/CAS
219-784-2/2530-83-8
Name of the chemical
[3-(2,3-epoxypropoxy)propyl]trimethoxy silane
Concentration
=1-<2,5
EC/CAS
209-136-7/556-67-2
Name of the chemical
D4
Concentration
>=0,025-<
EC/CAS
209-136-7/822-06-0
Name of the chemical
Hexamethylene diisocyanate
Concentration
<0,1 >=0,5% >=0,5%
EC/CAS
209-544-5/584-84-9
Name of the chemical
2,4-Diisocyanattoluol
Concentration
>=0,025-< >=0,1%
EC/CAS
212-485-8
Name of the chemical
Hexamethylene diisocyanate
Concentration
<0,1 >=0,5% >=0,5%
General Information
Version
12.0
Revision date
2024-11-25
Product name
PODKŁAD NA SZYBĘ DO KLEJU BASIC-30 ML
1.2.1 Relevant identified uses
Primers Professional use product
1.2.2. Uses advised against
May only be used by trained personnel on use
Icons in SDS
Company Information
company name
Wurth Polska Sp. z o.o
e-mail address of the competent person responsible for the Safety Data Sheet
prodsafe@wuerth.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H315, H317, H319, H334, H335, H336, H351, H412
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Signal word
Danger
Hazard statements
H225 Highly flammable liquid and vapour. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breath- ing difficulties if inhaled. H335 May cause respiratory irritation. H336 May cause drowsiness or dizziness. H351 Suspected of causing cancer. H412 Harmful to aquatic life with long lasting effects.
Prevention
P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P241 Use explosion-proof electrical/ ventilating/ lighting equipment. P242 Use non-sparking tools. P261 Avoid breathing mist or vapours. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P303 + P361 + P353 IF ON SKIN (or hair): Take off immedi- ately all contaminated clothing. Rinse skin with water. P321 Specific treatment (see supplemental first aid in- structions on this label). P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor. P370 + P378 In case of fire: Use water spray, alcohol- resistant foam, dry chemical or carbon dioxide to extinguish.
Storage
P403 + P233 Store in a well-ventilated place. Keep container tightly closed.
Hazardous Ingredients
Butanone Benzene, 2,4-diisocyanato-1-methyl-, polymer with 1,6-diisocyanatohexane Diphenylmethane diisocyanate, isomers and homologues Reaction mass of 4,4'-methylenediphenyl diisocyanate and o-(p-isocyanatobenzyl)phenyl isocyanate 4,4'-Diphenylmethane diisocyanate 4-Isocyanatosulphonyltoluene Hexamethylene diisocyanate, oligomers Hexamethylene diisocyanate 4-Methyl-m-phenylene diisocyanate
Additional information
EUH205 Contains epoxy constituents. May produce an allergic reaction. "As from 24 August 2023 adequate training is required before industrial or pro- fessional use."
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Excessive exposure may aggravate preexisting asthma and other respiratory disorders (e.g. em- physema, bronchitis, reactive airways dysfunction syndrome). Vapours may form explosive mixture with air.
